- Home
- Publications
- Publication Search
- Publication Details
Title
JAK inhibitors for asthma
Authors
Keywords
-
Journal
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 148, Issue 4, Pages 953-963
Publisher
Elsevier BV
Online
2021-10-06
DOI
10.1016/j.jaci.2021.08.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thymic Stromal Lymphopoietin Promotes MRGPRX2-Triggered Degranulation of Skin Mast Cells in a STAT5-Dependent Manner with Further Support from JNK
- (2021) Magda Babina et al. Cells
- Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program
- (2021) Philip G. Conaghan et al. DRUG SAFETY
- PrecISE: Precision Medicine in Severe Asthma An Adaptive Platform Trial with Biomarker Ascertainment
- (2021) Elliot Israel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases
- (2021) Esmee K. van der Ploeg et al. Science Immunology
- Ruxolitinib inhibits poly(I:C) and type 2 cytokines‐induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma
- (2021) Mitsuru Sada et al. Immunity Inflammation and Disease
- Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial
- (2021) Irene E. Braithwaite et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis
- (2021) Chong-xiang Chen et al. LEUKEMIA
- High-dimensional profiling clusters asthma severity by lymphoid and non-lymphoid status
- (2021) Matthew J. Camiolo et al. Cell Reports
- TEMPORARY REMOVAL: The association of plasma IL-6 with measures of asthma morbidity in a moderate-severe pediatric cohort aged 6-18 years
- (2021) Perdita Permaul et al. Journal of Allergy and Clinical Immunology-In Practice
- Local memory CD4 T cell niches in respiratory viral infection
- (2021) Kurt B. Pruner et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The molecular and epigenetic mechanisms of innate lymphoid cell (ILC) memory and its relevance for asthma
- (2021) Mukesh Verma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In Vivo CD4+ T Cell Differentiation and Function: Revisiting the Th1/Th2 Paradigm
- (2020) Mikel Ruterbusch et al. Annual Review of Immunology
- Incidence of cancer after asthma development: two independent population-based cohort studies
- (2020) Ala Woo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Therapeutic Efficacy of IL-17A Neutralization with Corticosteroid Treatment in a Model of Antigen-Driven Mixed Granulocytic Asthma
- (2020) Katherine E Menson et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Hypereosinophilic syndrome—a rare adverse event of anti-cytokine treatment in rheumatoid arthritis resolved after Janus kinase inhibitor therapy
- (2020) Emőke Šteňová et al. CLINICAL RHEUMATOLOGY
- Distinct functions of tissue-resident and circulating memory Th2 cells in allergic airway disease
- (2020) Rod A. Rahimi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Association of low-dosage systemic corticosteroid use with disease burden in asthma
- (2020) Kazuto Matsunaga et al. npj Primary Care Respiratory Medicine
- Therapeutic Effects of Intranasal Tofacitinib on Chronic Rhinosinusitis with Nasal Polyps in Mice
- (2020) Yeon‐Hee Joo et al. LARYNGOSCOPE
- Severe Adult Asthmas: Integrating Clinical Features, Biology and Therapeutics to Improve Outcomes
- (2020) Sally E. Wenzel AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review
- (2020) Jose María Álvaro-Gracia et al. Rheumatology and Therapy
- Venous Thromboembolism Risk With JAK Inhibitors: A Meta‐Analysis
- (2020) Mark Yates et al. Arthritis & Rheumatology
- Preformulation and Evaluation of Tofacitinib as a Therapeutic Treatment for Asthma
- (2019) Usir S. Younis et al. AAPS PHARMSCITECH
- Oral corticosteroid use, morbidity, and mortality in asthma: a nationwide prospective cohort study in Sweden
- (2019) Magnus Ekström et al. ALLERGY
- Estimation of Fraction Dissolved After Intratracheal Delivery of a Potent Janus Kinase Inhibitor, iJAK-001, with Low Solubility in Rat and Sheep: Impact of Preclinical PKPD on Inhaled Human Dose Projection
- (2019) Michael Caniga et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Novel inhaled pan-JAK inhibitor, LAS194046, reduces allergen-induced airway inflammation, late asthmatic response and pSTATs activation in Brown Norway rats.
- (2019) Marta Calbet et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients with Psoriatic Arthritis: A Pooled Analysis Across Phase 3 and Long‐Term Extension Studies
- (2019) Dafna D Gladman et al. ARTHRITIS CARE & RESEARCH
- Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling
- (2019) Mark Zak et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management
- (2019) Eugene R Bleecker et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma
- (2019) Xingnan Li et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma
- (2019) Jonathan Corren et al. Journal of Allergy and Clinical Immunology-In Practice
- Inhaled Janus Kinase (JAK) inhibitors for the treatment of asthma
- (2019) Mark Zak et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases
- (2019) Jordi Bach et al. JOURNAL OF MEDICINAL CHEMISTRY
- IL-4Rα expression by airway epithelium and smooth muscle accounts for nearly all airway hyperresponsiveness in murine allergic airway disease
- (2019) Christopher G. McKnight et al. Mucosal Immunology
- IL-17 receptor–based signaling and implications for disease
- (2019) Xiaoxia Li et al. NATURE IMMUNOLOGY
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- (2019) Michael D. Howell et al. Frontiers in Immunology
- IL-13 and IL-4, but not IL-5 nor IL-17A, induce hyperresponsiveness in isolated human small airways
- (2019) Martijn L. Manson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- JAK Inhibition Differentially Affects NK Cell and ILC1 Homeostasis
- (2019) Laura Vian et al. Frontiers in Immunology
- JAK/STAT inhibitors and other small molecule cytokine antagonists for the treatment of allergic disease
- (2018) Michael D. Howell et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Signaling and Function of Interleukin-2 in T Lymphocytes
- (2018) Sarah H. Ross et al. Annual Review of Immunology
- The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release
- (2018) M.A.W. Hermans et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Baricitinib: A Review in Rheumatoid Arthritis
- (2018) Zaina T. Al-Salama et al. DRUGS
- Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids
- (2018) Michael C. Peters et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation
- (2018) Zala Jevnikar et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin
- (2018) Sucai Liu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs
- (2018) Massimo Gadina et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma
- (2018) Hart S. Dengler et al. Science Translational Medicine
- JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome
- (2017) Kate L. Del Bel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of tofacitinib on lipid levels and lipid-related parameters in patients with moderate to severe psoriasis
- (2017) Robert Wolk et al. Journal of Clinical Lipidology
- Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib
- (2017) Brett King et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin
- (2017) Peter Jones et al. JOURNAL OF MEDICINAL CHEMISTRY
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- The emerging safety profile of JAK inhibitors in rheumatic disease
- (2017) Kevin L. Winthrop Nature Reviews Rheumatology
- KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma
- (2017) Katherine N. Cahill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe and Difficult-to-Treat Asthma in Adults
- (2017) Elliot Israel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma
- (2017) Antonio Aguilar-Pimentel et al. PLoS One
- Tofacitinib ameliorates inflammation in a rat model of airway neutrophilia induced by inhaled LPS
- (2017) Elena Calama et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Risks of malignancies related to tofacitinib and biological drugs in rheumatoid arthritis: Systematic review, meta-analysis, and network meta-analysis
- (2017) José Ramón Maneiro et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
- (2017) Akbar K Waljee et al. BMJ-British Medical Journal
- Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
- (2017) Akbar K Waljee et al. BMJ-British Medical Journal
- Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy
- (2017) Kevin L. Winthrop et al. Arthritis & Rheumatology
- Interleukin-2-Dependent Allergen-Specific Tissue-Resident Memory Cells Drive Asthma
- (2016) Brian D. Hondowicz et al. IMMUNITY
- Current concepts of severe asthma
- (2016) Anuradha Ray et al. JOURNAL OF CLINICAL INVESTIGATION
- Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts
- (2016) Michael C Peters et al. Lancet Respiratory Medicine
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis
- (2015) Cecilia Arana Yi et al. Future Oncology
- The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling
- (2015) Wataru Amano et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- High IFN-γ and low SLPI mark severe asthma in mice and humans
- (2015) Mahesh Raundhal et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate
- (2014) Edward C Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Epithelial barrier function: At the front line of asthma immunology and allergic airway inflammation
- (2014) Steve N. Georas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
- (2013) William W. Busse et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment
- (2013) B. Strober et al. BRITISH JOURNAL OF DERMATOLOGY
- Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses
- (2013) Shigeru Ashino et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A Restricted Role for TYK2 Catalytic Activity in Human Cytokine Responses Revealed by Novel TYK2-Selective Inhibitors
- (2013) S. J. Sohn et al. JOURNAL OF IMMUNOLOGY
- Tofacitinab in Renal Transplantation
- (2013) Martin S. Zand Transplantation Reviews
- Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
- (2012) Christina E. Zielinski et al. NATURE
- The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling
- (2012) Nicholas A. Pullen et al. Frontiers in Immunology
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- The Jak Inhibitor CP-690,550 Preserves the Function of CD4+CD25brightFoxP3+ Regulatory T Cells and Inhibits Effector T Cells
- (2010) V. D. K. D. Sewgobind et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Effects of a Janus kinase inhibitor, pyridone 6, on airway responses in a murine model of asthma
- (2010) Yuko Matsunaga et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells
- (2010) Philip P. Ahern et al. IMMUNITY
- Generation of pathogenic TH17 cells in the absence of TGF-β signalling
- (2010) Kamran Ghoreschi et al. NATURE
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
- (2009) Prescott G. Woodruff et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia
- (2008) Elizabeth Kudlacz et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started